POZEN, Inc. (NASDAQ:POZN)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Recs

0
Player Avatar pchop123 (79.46) Submitted: 12/19/2012 3:46:54 PM : Outperform Start Price: $5.15 POZN Score: +8.07

Far more upside than downside for the moment

Featured Broker Partners


Advertisement